{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:55:37Z","timestamp":1790434537913,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["KONTAKT LH12004"],"award-info":[{"award-number":["KONTAKT LH12004"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["MUNI\/A\/0810\/2016"],"award-info":[{"award-number":["MUNI\/A\/0810\/2016"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["14-31540S"],"award-info":[{"award-number":["14-31540S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.joca.2017.05.014","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T02:16:10Z","timestamp":1496456170000},"page":"1522-1530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Statins do not inhibit the FGFR signaling in chondrocytes"],"prefix":"10.1016","volume":"25","author":[{"given":"B.","family":"Fafilek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2824-1004","authenticated-orcid":false,"given":"M.","family":"Hampl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ricankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5751-0130","authenticated-orcid":false,"given":"I.","family":"Vesela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Balek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kunova Bosakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gudernova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Varecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Buchtova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0618-9134","authenticated-orcid":false,"given":"P.","family":"Krejci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2017.05.014_bib1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","article-title":"Pleiotropic effects of statins. Basic research and clinical perspectives","volume":"74","author":"Zhou","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.joca.2017.05.014_bib2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clinbiochem.2007.03.016","article-title":"Mevalonate pathway: a review of clinical and therapeutical implications","volume":"40","author":"Buhaescu","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/j.joca.2017.05.014_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13775","article-title":"Statin treatment rescues FGFR3 skeletal dysplasia phenotypes","volume":"513","author":"Yamashita","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.joca.2017.05.014_bib4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","article-title":"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia","volume":"371","author":"Rousseau","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.joca.2017.05.014_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ng0595-11","article-title":"Stop codon FGFR3 mutations in thanatophoric dwarfism type 1","volume":"10","author":"Rousseau","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.joca.2017.05.014_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.joca.2017.05.014_bib7","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in\u00a0vitro and in rodents by statins","volume":"286","author":"Mundy","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.joca.2017.05.014_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1592\/phco.25.2.228.56954","article-title":"Statins and osteoporosis: a clinical review","volume":"25","author":"Gonyeau","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.joca.2017.05.014_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1124\/jpet.114.218560","article-title":"Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism","volume":"353","author":"Wendt","year":"2015","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.joca.2017.05.014_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","article-title":"Fibroblast growth factor receptor 3 is a negative regulator of bone growth","volume":"84","author":"Deng","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.joca.2017.05.014_bib11","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1093\/hmg\/6.11.1899","article-title":"Abnormal FGFR 3 expression in cartilage of thanatophoric dysplasia fetuses","volume":"6","author":"Delezoide","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.joca.2017.05.014_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/8.1.35","article-title":"A\u00a0Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors","volume":"8","author":"Li","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.joca.2017.05.014_bib13","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1172\/JCI6690","article-title":"Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis","volume":"104","author":"Chen","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.joca.2017.05.014_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1073\/pnas.2237184100","article-title":"Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia","volume":"101","author":"Cho","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.joca.2017.05.014_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.286.5438.309","article-title":"The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase","volume":"286","author":"Joazeiro","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.joca.2017.05.014_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-5793(02)03255-6","article-title":"FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation","volume":"528","author":"Monsonego-Ornan","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.joca.2017.05.014_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.joca.2015.01.002","article-title":"A\u00a0new prescription for growth? Statins, cholesterol and cartilage homeostasis","volume":"23","author":"Bush","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2017.05.014_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/hmg\/ddv441","article-title":"Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes","volume":"25","author":"Gudernova","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.joca.2017.05.014_bib19","doi-asserted-by":"crossref","first-page":"27711","DOI":"10.1074\/jbc.270.46.27711","article-title":"Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro-alpha 1(II) collagen gene","volume":"270","author":"Mukhopadhyay","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.joca.2017.05.014_bib20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.joca.2017.05.014_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.yexcr.2004.03.011","article-title":"FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells","volume":"297","author":"Krejci","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.joca.2017.05.014_bib22","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1074\/jbc.M310384200","article-title":"Activation of the ERK1\/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes","volume":"279","author":"Raucci","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.joca.2017.05.014_bib23","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1158\/0008-5472.CAN-11-3034","article-title":"AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family","volume":"72","author":"Gavine","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.joca.2017.05.014_bib24","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.bbadis.2014.12.020","article-title":"Fibroblast growth factor and canonical WNT\/\u03b2-catenin signaling cooperate in suppression of chondrocyte differentiation in experimental models of FGFR signaling in cartilage","volume":"1852","author":"Buchtova","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.joca.2017.05.014_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bone.2010.03.021","article-title":"FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence","volume":"47","author":"Krejci","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.joca.2017.05.014_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/humu.21636","article-title":"Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias","volume":"33","author":"Foldynova-Trantirkova","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.joca.2017.05.014_bib27","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1021\/jm2006222","article-title":"Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase","volume":"54","author":"Guagnano","year":"2011","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.joca.2017.05.014_bib28","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11626-999-0070-0","article-title":"High density micromass cultures of embryonic limb bud mesenchymal cells: an in\u00a0vitro model of endochondral skeletal development","volume":"35","author":"Mello","year":"1999","journal-title":"In\u00a0Vitro Cell Dev Biol Anim"},{"key":"10.1016\/j.joca.2017.05.014_bib29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1083\/jcb.200205025","article-title":"FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest","volume":"158","author":"Laplantine","year":"2002","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.joca.2017.05.014_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jcp.20923","article-title":"Fibroblast growth factors 2, 4, and 8 exert both negative and positive effects on limb, frontonasal, and mandibular chondrogenesis via MEK-ERK activation","volume":"211","author":"Bobick","year":"2007","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.joca.2017.05.014_bib31","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1182\/blood-2006-09-047076","article-title":"Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation","volume":"109","author":"Dai","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.joca.2017.05.014_bib32","doi-asserted-by":"crossref","first-page":"e3961","DOI":"10.1371\/journal.pone.0003961","article-title":"Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage","volume":"3","author":"Krejci","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.joca.2017.05.014_bib33","doi-asserted-by":"crossref","first-page":"17344","DOI":"10.1074\/jbc.M212710200","article-title":"The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3), which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum","volume":"278","author":"Lievens","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.joca.2017.05.014_bib34","doi-asserted-by":"crossref","first-page":"13272","DOI":"10.1074\/jbc.M110.205583","article-title":"FGFR3 heterodimerization in achondroplasia, the most common form of human dwarfism","volume":"286","author":"He","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.joca.2017.05.014_bib35","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1182\/blood-2012-01-403493","article-title":"Fluvastatin inhibits FLT3 glycosylation in human and murine cells and prolongs survival of mice with FLT3\/ITD leukemia","volume":"120","author":"Williams","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.joca.2017.05.014_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157488609789006949","article-title":"Adverse effects of statins \u2013 mechanisms and consequences","volume":"4","author":"Be\u0142towski","year":"2009","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.joca.2017.05.014_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.103.1.113","article-title":"Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance","volume":"103","author":"Feron","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.joca.2017.05.014_bib38","first-page":"1037","article-title":"Synergistic effects of lovastatin and celecoxib on caveolin-1 and its down-stream signaling molecules: implications for colon cancer prevention","volume":"35","author":"Guruswamy","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1016\/j.joca.2017.05.014_bib39","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1161\/01.CIR.0000065601.83526.3E","article-title":"Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-\/- mice in\u00a0vivo","volume":"107","author":"Pelat","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.joca.2017.05.014_bib40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2125.2011.03907.x","article-title":"What is a relevant statin concentration in cell experiments claiming pleiotropic effects?","volume":"72","author":"Bj\u00f6rkhem-Bergman","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.joca.2017.05.014_bib41","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1203\/00006450-199606000-00016","article-title":"Differential effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on the development of myopathy in young rats","volume":"39","author":"Reijneveld","year":"1996","journal-title":"Pediatr Res"},{"key":"10.1016\/j.joca.2017.05.014_bib42","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s00776-003-0724-9","article-title":"Statin stimulates bone morphogenetic protein-2, aggrecan, and type 2 collagen gene expression and proteoglycan synthesis in rat chondrocytes","volume":"8","author":"Hatano","year":"2003","journal-title":"J\u00a0Orthop Sci"},{"key":"10.1016\/j.joca.2017.05.014_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1203\/pdr.0b013e318030d157","article-title":"Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage","volume":"61","author":"Krejci","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1016\/j.joca.2017.05.014_bib44","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.tiv.2012.06.013","article-title":"Simvastatin modulates mouse embryonic stem cell-derived chondrogenesis in\u00a0vitro","volume":"26","author":"Kramer","year":"2012","journal-title":"Toxicol In\u00a0Vitro"},{"key":"10.1016\/j.joca.2017.05.014_bib45","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/mol.112.078915","article-title":"Cholesterol-lowering drugs inhibit lectin-like oxidized low-density Lipoprotein-1 receptor function by membrane raft disruption","volume":"82","author":"Matarazzo","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.joca.2017.05.014_bib46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejphar.2015.07.024","article-title":"Comparative evaluation of HMG CoA reductase inhibitors in experimentally-induced myocardial necrosis: biochemical, morphological and histological studies","volume":"764","author":"Variya","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.joca.2017.05.014_bib47","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-199732050-00005","article-title":"Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors \u2013 similarities and differences","volume":"32","author":"Lennernas","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.joca.2017.05.014_bib48","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/79510","article-title":"The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals","volume":"6","author":"Kureishi","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.joca.2017.05.014_bib49","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1074\/jbc.M606706200","article-title":"Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation","volume":"282","author":"Ghosh-Choudhury","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.joca.2017.05.014_bib50","doi-asserted-by":"crossref","first-page":"e1002224","DOI":"10.1371\/journal.pgen.1002224","article-title":"Cholesterol metabolism is required for intracellular hedgehog signal transduction in\u00a0vivo","volume":"7","author":"Stottmann","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.joca.2017.05.014_bib51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1083\/jcb.200401138","article-title":"Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling","volume":"166","author":"Fujita","year":"2004","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.joca.2017.05.014_bib52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0925-4773(99)00339-1","article-title":"Embryonic stem cell-derived chondrogenic differentiation in\u00a0vitro: activation by BMP-2 and BMP-4","volume":"92","author":"Kramer","year":"2000","journal-title":"Mech Dev"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458417310245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458417310245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:45:52Z","timestamp":1761018352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458417310245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1063458417310245"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2017.05.014","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins do not inhibit the FGFR signaling in chondrocytes","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2017.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Osteoarthritis Research Society International. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}